Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HYTN Innovations Inc C.HYTN

Alternate Symbol(s):  HYTNF

Energy Oil & Gas E&P
HYTN Innovations Inc. is a Canada-based company that creates products containing psychoactive and psychotropic compounds, including cannabinoids derived from cannabis. It formulates, manufactures, markets, and sells cannabis goods. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. All its sparkling cannabis beverages contain 10... see more

Recent & Breaking News (CSE:HYTN)

HYTN Announces Marketing Program

GlobeNewswire November 8, 2024

HYTN Expands GMP Capabilities with New Licensed Activity

GlobeNewswire October 9, 2024

HYTN Files Business Acquisition Report

GlobeNewswire September 27, 2024

HYTN Partners with the UK's 4C Labs, Validates GMP Certification

GlobeNewswire September 10, 2024

HYTN Lists on the OTC Pink Market

GlobeNewswire July 29, 2024

HYTN Completes Acquisition of Prism Scientific Labs, Enhancing Psychedelic Compound Manufacturing Capabilities

GlobeNewswire July 20, 2024

HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities

GlobeNewswire June 27, 2024

HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, Foresees Growth

GlobeNewswire May 1, 2024

HYTN Innovates GMP Stability Programs, Sets Industry Benchmark

GlobeNewswire April 22, 2024

HYTN Welcomes Health Canada for Audit to Enhance GMP Capabilities

GlobeNewswire April 9, 2024

HYTN Provides Corporate Update, Outlines New Global Direction

GlobeNewswire April 3, 2024

HYTN Secures GMP Certification

GlobeNewswire March 21, 2024

HYTN Clears PIC/S GMP Audit, Primed for Global Expansion

GlobeNewswire March 4, 2024

HYTN Broadens Reach with Innovative Cannabis-Infused Nano Shot

GlobeNewswire February 20, 2024

HYTN Announces Non-Brokered Private Placement for up to C$1 Million

GlobeNewswire February 9, 2024

HYTN Announces Closing of Non-Brokered Private Placement Under Listed Issuer Financing Exemption

GlobeNewswire October 26, 2023

HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine

GlobeNewswire March 2, 2023

HYTN (CSE:HYTN) begins cultivating psilocybin mushrooms

John Ballem  February 23, 2023

HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development

GlobeNewswire February 23, 2023

HYTN Innovations Advances Active Pharmaceutical Ingredient Portfolio and Increases Sales of Rapid Onset Cannabis Products Using Proprietary Elevation Technology

GlobeNewswire February 16, 2023